Navigation Links
Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
Date:10/10/2007

ARLINGTON HEIGHTS, Ill., Oct. 10 /PRNewswire-USNewswire/ -- Face transplants, once on the fringe of medicine, may eventually become more mainstream because of new estimates that suggest the risk of tissue rejection might be lower than previously thought, according to a recent review in Plastic and Reconstructive Surgery(R) (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS).

"We can only know the true immunological risks associated with face transplants by carefully observing those who have already had the procedure," said ASPS President Roxanne Guy, MD. "While this paper doesn't provide conclusive evidence of the immunological risks, it will help us move forward in making face transplants part of mainstream medicine."

Currently, immunosuppressive drugs are the biggest barrier the medical community faces in performing any transplant because the potential long-term side effects of these medications can make the risk too great.

The authors suggest previous immunological risk projections are inaccurate because they were based on immunosuppression drug regimes that are different than the regimes that will be required of face transplant patients.

When utilizing an immunosuppressive drug regimen consistent with face transplant recipient requirements, the authors believe patients would have a relatively low risk of chronic or continual rejection after surgery -- less than 10 percent. In addition, advances in immunosuppression therapies have increased the capacity to manage face transplant patients and potentially reduce acute or immediate rejection episodes.

The authors also suggest that the immunological risks are lower because face transplant patients may on average be healthier and less likely to suffer from extenuating health issues. Organ transplant recipients, on the other hand, often are extremely sick and have numerous, pre-existing health conditions that make them more susceptible to the
'/>"/>

SOURCE American Society of Plastic Surgeons
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
2. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
3. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
4. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
5. Neurogen Proprietary Insomnia Compound Data Presented at Associated Professional Sleep Societies Annual Meeting
6. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
7. Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the Annual Meeting of the Associated Professional Sleep Societies
8. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
9. Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntingtons Disease
10. Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions
11. Insmed Releases Positive Results from Iplex Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)...cted in November 2008, BOTHELL, Wash., Oct. 9 /PR...DDD ) announced today the completion of patient en...otal trials to evaluate the safety and,efficacy of...ibuprofen for,the over-the-counter (OTC) market. T... this pivotal trial in November 2008. Ibuprofen is...
(Date:10/8/2008)...swire-USNewswire/ -- The facts are,overwhelming. E...,sub-Saharan Africa. More than 35,000,000 women, c...y died of AIDS. The Foundation for Hospices,in Sub... their families,find compassion and relief from su...tnering initiative links African hospices and pall...
(Date:10/8/2008)...rs Research That May Offer New Hope to,Heart Failu...onally, over 3,000 people are,waiting for a heart ...half,of those will receive a transplant. Now, pion...s paving the way for how to treat congestive heart...News Release, go to:, http://www.prnewswire.com/mn...
(Date:10/8/2008)...te TAXUS(R) Element(TM) Platinum Chromium .... 8 /- Boston Scientific,Co...s completed enrollment in,the PERSEUS trial, desig...US(R) Element(TM) paclitaxel-eluting coronary sten...y 1,500 patients at 100 U.S. and,international cen...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4New Water Purification Product from Reliance Products and Procter 26 Gamble now Available in Retail Stores 11932 1New Water Purification Product from Reliance Products and Procter 26 Gamble now Available in Retail Stores 11932 2New Water Purification Product from Reliance Products and Procter 26 Gamble now Available in Retail Stores 11932 3LodgeNet Interactive Corporation 2007 Earnings Release and Teleconference Announcement 11927 1LodgeNet Interactive Corporation 2007 Earnings Release and Teleconference Announcement 11927 2Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 1Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 2Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 3Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings 11925 4NIH report on intracranial stent points out need for upcoming large scale clinical trial 11921 1NIH report on intracranial stent points out need for upcoming large scale clinical trial 11921 2
...e 07, 2007 /PRNewswire-FirstCall/ -,Neurochem (Int...bsidiary of Neurochem Inc. , announces that the Ne... results of the "Eprodisate,For AA Amyloidosis Tri...al in the search for a treatment of AA amyloidosis...or eprodisate,(KIACTA(TM)) demonstrate that this p...
...zonisamide SR as a novel component in,EMPATIC(TM) .../PRNewswire-FirstCall/ -- Orexigen(TM),Therapeutic...he,treatment of central nervous system disorders w...esults from a Phase I trial evaluating,safety and ...ned-release (SR) formulation of zonisamide. In the...
Other Medicine Technology:Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 2Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 3Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 4Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis 5OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
(Date:10/10/2008)...pon the completion of a highly successful CIO Fina...udly announces their next business technology gath...ogy executives in healthcare. CDM Media has confir...2, 2009 at the Four Seasons Resort in Scottsdale, ...) October 11, 2008 -- Upon the completion of a hig...
(Date:10/10/2008)...lif., Oct. 10 /PRNewswire/ -- A senior citizen,soa...ntains in a small,plane. The high-flying adventure...The thrill came from a last-wish program through S...or Living, where Heden was a patient.,Called Go Wi... has helped,many realize a special activity at the...
(Date:10/10/2008)...n could lessen long-term side effects, study finds...- Using chemotherapy alone, and delaying or avoidi...ing children with inoperable or progressive low-gr...itutional study. , Low-grade glioma is the most... performed, the survival rate for patients is 95 p...
(Date:10/10/2008)...alth (NIH) scientists have identified a protein th... blood cells, T and B cells, enabling them to inte...-lasting immunity after an infection. Their findi...a genetic defect that prevents them from making th...with a common virus that otherwise is rarely fatal...
Breaking Medicine News(10 mins):Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Chemo Alone Effective in Treating Kids' Brain Tumors 2Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3
...lhi, June 1: The apex consumer court in New Delhi ...mpensation case of claim that was filed by an Indi... his wife in 1998, which he alleged due to the wro...rom Ohio Saha said that the judgement of the Natio...
...y on manslaughter by doctors in UK, says that many...n named Steven Walker was found to be convicted //...found that conviction was low. Due to vengeance a... Hospital researchers found 85 doctors had been ch...
...ndition of Rahul Mahajan, son of late BJP leader P...s admitted to a private hopital here in the wee ho... brought in dead. 'Rahul's condition is serious bu...ametres are functioning normally', Apollo hospital...
...lhi. The National Consumer Commission today dismis... 143 Crores filed by a US-based doctor //who had a...ven at a Kolkata hospital. The National Consumer D...prising Justice M B Shah, Justice K S Gupta and Me...
Other Medicine News:Health News:Court Dismisses 143-Crore Claim Against Hospital In Kolkata For Alleged Negligence In Treatment 2Health News:Court Dismisses 143-Crore Claim Against Hospital In Kolkata For Alleged Negligence In Treatment 3
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: